Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells

Hepatocellular carcinoma (HCC) is an aggressive and incurable cancer. Although understanding of the molecular pathogenesis of HCC has greatly advanced, therapeutic options for the disease remain limited. In this study, we demonstrated that SETD5 expression is positively associated with poor prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mijin, Moon, Byul, Kim, Jong-Hwan, Park, Seung-Jin, Kim, Seon-Kyu, Park, Kihyun, Kim, Jaehoon, Kim, Seon-Young, Kim, Jeong-Hoon, Kim, Jung-Ae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385566/
https://www.ncbi.nlm.nih.gov/pubmed/35950456
http://dx.doi.org/10.14348/molcells.2022.0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385566/
https://www.ncbi.nlm.nih.gov/pubmed/35950456
http://dx.doi.org/10.14348/molcells.2022.0009

Ejemplares similares